Sector revisions Metropolis Healthcare Limited

Equities

End-of-day quote NSE India S.E. Other stock markets 2026-01-09			5-day change	1st Jan Change
1,920.40 ^INR	+0.22%		-0.67%	-0.44%

Jan. 04	Metropolis Health standalone revenue growth at 15% YoY	RE
Nov. 06	Metropolis Healthcare Limited, Q2 2026 Earnings Call, Nov 06, 2025

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	4m. EPS revision	4m. Revenue rev.	1y. EPS revision	1y. Revenue rev.	Visibility	Nbr of analysts
METROPOLIS HEALTHCARE LIMITED						19
NATERA, INC.						20
SONIC HEALTHCARE LIMITED						14
RADNET, INC.						8
GENEDX HOLDINGS CORP.						9
DR. LAL PATHLABS LIMITED						26
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.						6
DIAN DIAGNOSTICS GROUP CO.,LTD.						6
ULTRAGREEN.AI LIMITED	-	-	-	-	-	1
NEOGENOMICS, INC.						8
FLEURY S.A.						10
H.U. GROUP HOLDINGS, INC.						4
VIJAYA DIAGNOSTIC CENTRE LIMITED						10
OPKO HEALTH, INC.						6
BML, INC.					-	1
NOVOGENE CO., LTD.						3
FULGENT GENETICS, INC.						3
THYROCARE TECHNOLOGIES LIMITED						3
SMO CLINPLUS CO.,LTD.					-	1
Average						8
Weighted average by Cap.						14